Obese adults facing Medicaid expansion gap

Despite overall increases in insurance coverage for low-income individuals in Medicaid expansion states, some gaps remain for individuals who are obese. That’s according to a recent study by a team of researchers at the University of Georgia. The findings, published in the journal Obesity, show a slower uptake of Medicaid enrollment among low-income obese individuals…

Details

UBC discovery opens new avenues for designing drugs to combat drug-resistant malaria

For the first time, UBC researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart. The finding, recently published in the International Union of Crystallography Journal, brings researchers one step closer to developing new therapies to combat drug-resistant malaria.…

Details

Two new AHA statements focus on heart failure: How social determinants can affect outcomes; impact on caregivers

DALLAS, April 30, 2020 — Treatment for heart failure should take into consideration a patient’s social determinants of health – their overall living environment, socio-economic status, as well as the needs of unpaid family caregivers, according to two new scientific statements from the American Heart Association, published simultaneously today in the Association’s flagship journal Circulation.…

Details

Fecal transplantation improves outcomes in patients with multi-drug resistant organisms

Bethesda, MD (April 30, 2020) — Transferring fecal matter from the digestive systems of healthy donors to extremely ill patients who had previously been infected with drug-resistant bacteria resulted in shorter hospital stays, fewer bloodstream infections and infections that were easier to treat, according to research that was selected for presentation at Digestive Disease Week®…

Details

Live Updates: F.D.A. Plans to Announce Emergency Use of Coronavirus Drug

Here’s what you need to know: ImageLab technicians loading vials of remdesivir, an experimental antiviral drug to treat the coronavirus, at a Gilead Sciences facility last month in California.Credit…Gilead Sciences, via Reuters The early results of a federal trial showing that treatment with remdesivir, an experimental antiviral drug, can speed recovery in patients infected with…

Details